A panel of health experts convened this week to decide which vaccine the U.S. should use against COVID-19 this fall. The federal advisory group decided on Wednesday the new vaccine should focus on the ...
In a recent study posted to the bioRxiv* preprint server, researchers in Italy performed a genome-based comparison of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback